What is the evidence that ecstasy (MDMA) can cause Parkinson's disease?

被引:24
|
作者
Kish, SJ [1 ]
机构
[1] Ctr Addict & Mental Hlth, Human Neurochem Pathol Lab, Toronto, ON, Canada
关键词
D O I
10.1002/mds.10643
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:1219 / 1223
页数:5
相关论文
共 50 条
  • [1] What's in a Name? Correlates of Ecstasy Users Knowing or Agreeing that Molly is Ecstasy/MDMA
    Palamar, Joseph J.
    [J]. JOURNAL OF PSYCHOACTIVE DRUGS, 2018, 50 (01) : 88 - 93
  • [2] Can neuroleptic drugs cause Parkinson's disease?
    Mazurek, MF
    Kolbasnik, A
    Garside, S
    Levinson, A
    Rosebush, P
    [J]. ANNALS OF NEUROLOGY, 1999, 46 (03) : 478 - 478
  • [3] Exposure to Pesticides Can Cause Parkinson's Disease
    Andy Coghlan
    林晓晶
    [J]. 当代外语研究, 2005, (07) : 8 - 5
  • [4] Chronotypes in Parkinson's Disease: What Are They? And What Can They Predict?
    Sarwar, Aliya I.
    Varghese, Robin
    Hirshkowitz, Max
    Lai, Eugene C.
    John-son, Shawna
    Hou, Jyh-Gong
    [J]. NEUROLOGY, 2011, 76 (09) : A438 - A438
  • [5] A new cause of valvular heart disease: 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy')
    Montastruc, F.
    Montastruc, G.
    Vigreux, P.
    Bruneval, P.
    Guilbeau-Frocher, C.
    Cron, C.
    Bagheri, H.
    Delisle, B.
    Lapeyre-Mestre, M.
    Pathak, A.
    Montastruc, J. L.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2012, 26 : 10 - 10
  • [6] Can the 2019 Novel Coronavirus Cause Parkinson's Disease?
    Achbani, Abderrahmane
    Sine, Hasnaa
    Naciri, Aziz
    Baba, Mohamed Amine
    Kharbach, Ahmed
    Bouchriti, Youssef
    Nejmeddine, Mohamed
    [J]. MOVEMENT DISORDERS, 2020, 35 (07) : 1102 - 1103
  • [7] Parkinson's disorder, psychomotor problems and dopaminergic neurotoxicity in recreational ecstasy/MDMA users
    A. C. Parrott
    T. Buchanan
    T. M. Heffernan
    A. Scholey
    J. Ling
    J. Rodgers
    [J]. Psychopharmacology, 2003, 167 : 449 - 450
  • [8] Parkinson's disorder, psychomotor and dopaminergic neurotoxicity in problems recreational ecstasy/MDMA users
    Parrott, AC
    Buchanan, T
    Heffernan, TM
    Scholey, A
    Ling, J
    Rodgers, J
    [J]. PSYCHOPHARMACOLOGY, 2003, 167 (04) : 449 - 450
  • [9] Metabolic abnormalities in Parkinson's disease: Evidence for a neurotoxic cause?
    Newbold, SG
    Rostami-Hodjegan, A
    Lennard, MS
    Tucker, GT
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2002, 73 (02): : 231 - 231
  • [10] What evidence is there that the methamphetamine is a significant issue in the UK compared to established recreational drugs such as MDMA ('Ecstasy')?
    Wood, D. M.
    Button, J.
    Ashraf, T.
    Walker, S.
    Greene, S. L.
    Drake, N.
    Ramsey, J.
    Holt, D. W.
    Dargan, P., I
    [J]. CLINICAL TOXICOLOGY, 2008, 46 (05) : 388 - 389